Breaking News, Collaborations & Alliances

Almac To Perform Analytics for Alzheimer’s Test

Diagnostic unit gains second commercial clinical test contract.

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Almac’s Diagnostics unit will be the central service lab to perform the analytic phase and results delivery to clinicians of Exonhit‘s AclarusDx diagnostic test. Exonhit AclarusDx is a micro-array-based test intended to aid in the diagnosis of Alzheimer’s disease (AD) by detecting biomarkers specific for AD in peripheral blood. The test was CE marked in March 2011 and has now been introduced for clinical diagnostic use in France. The test will be performed by Almac from its ISO17025-accre...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters